1. Introduction {#sec1}
===============

Adducin (ADD) is a heterodimeric cytoskeleton protein consisting of an *α*-subunit with either a *β*- or a *γ*-subunit \[[@B1]\], and they are encoded by three different genes *ADD1*, *ADD2*, and *ADD3*, respectively. The *α*-subunit is known to increase renal sodium reabsorption and may be involved in the pathophysiology of essential hypertension \[[@B2]\]. Therefore, it is considered as a major candidate gene for essential hypertension. Not surprisingly, a number of studies have investigated the association of *α*-adducin gene (*ADD1*) polymorphisms with essential hypertension in the past two decades.

Human *ADD1* gene is located on chromosome 4p16.3 and comprises 16 exons. One well-studied polymorphism in *ADD1*gene is a substitution of Gly for Trp at amino acid residue 460 (G460W, rs4961), which was first described by Cusi et al. \[[@B3]\]. *ADD1*W460W was found to be associated with a form of low renin salt-sensitive hypertension in Caucasians, with reduced response to pressure natriuretic function and with increased proximal sodium reabsorption \[[@B4], [@B5]\]. Therefore, although a great number of similar studies have been conducted, the results are often inconsistent.

To convince the association of this polymorphism with essential hypertension, several meta-analyses were recently published \[[@B6]--[@B10]\]. Most of these analyses failed to provide evidence for the genetic association of *ADD1*G460W polymorphism with essential hypertension in global population; but it is suggested that the W carrier might increase the risk of essential hypertension in Han Chinese population \[[@B7]\]. However, most studies focus on *ADD1*G460W polymorphism, and whether other single nucleotide polymorphisms (SNPs) in *ADD1*gene were associated with essential hypertension is not clear. Therefore, we carried out a case-control study and an interaction analysis to verify whether *ADD1* gene is associated with hypertension in the Chinese population.

2. Materials and Methods {#sec2}
========================

2.1. Population for Case-Control Study {#sec2.1}
--------------------------------------

The participants were chosen from our established community-based epidemiology study of common diseases. We have collected more than 10,000 health records. Subsequently, participants who fulfilled the following criteria were put into our database: 30 to 75 years old, Han Chinese, living in Ningbo City (East Coast of China) for at least three generations and do not have a migration history. The hypertensive subjects and control subjects were matched for age and sex. In addition, only subjects who do not have other cardiovascular disease or major chronic illnesses according to their health records were included in the control group. Lastly, 905 essential hypertension cases and 905 healthy controls, including 392 males and 513 females in each group, were involved in the following studies.

2.2. Blood Pressure and Clinical Parameters {#sec2.2}
-------------------------------------------

Blood pressure measurements were conducted in the morning after the participant had been in the sitting position for 10 minutes. Three BP measurements were obtained at 5-minute intervals using standard mercury sphygmomanometer, and the average of last two measurements was taken as the BP for that participant. Hypertension in this study is defined as a sitting systolic blood pressure (SBP) ≥ 140 mmHg and/or a diastolic blood pressure (DBP) ≥ 90 mmHg, or self-reported use of antihypertension medication (also confirmed by health records). Patients with secondary hypertension were excluded. Normal blood pressure is defined with SBP ≤ 120 mmHg and DBP ≤ 80 mmHg.

Blood samples were collected with informed consent. Subsequently, total cholesterol (TC), high density lipoprotein (HDL), and triglyceride (TG) were measured from these blood samples by Hitachi automatic biochemistry analyzer 7100. Clinical information including body mass index (BMI), and weekly alcohol and cigarettes consumption were also obtained. In this study, who drank ≥70 g alcohol per week for more than 1 year were defined as individuals with alcohol abuse. Moreover, who smoked ≥70 cigarettes per week for more than 1 year were defined as individuals with smoking habit. The protocol of this study was reviewed and approved by the Ethics Committees of Ningbo University.

2.3. SNP Genotyping {#sec2.3}
-------------------

All six tagSNPs were retrieved from HapMap (<http://hapmap.ncbi.nlm.nih.gov/>), with tagger pairwise method in CHB: *R* Square cut off = 0.8 and MAF cut off = 0.1. Genomic DNA was obtained from the whole blood using standard phenol/chloroform extraction. Genotyping was performed using the GenomeLab SNPstream Genotyping System (Beckman Coulter Inc.) according to the manufacturer\'s protocol \[[@B11]\].

2.4. Statistical Analysis {#sec2.4}
-------------------------

Continuous variables are presented as the mean ± SD and analyzed by *t*-test between two groups. Statistical analyses of allele and genotype frequencies between hypertensive cases and healthy controls and between different sex groups were performed by chi-squared test (SPSS 16.0, SPSS Inc.). Hardy-Weinberg equilibrium (HWE) was tested by the software PEDSTATS V0.6.8 (<http://www.sph.umich.edu/csg/abecasis/>). Linkage equilibrium (LD) blocks were defined based on the confidence intervals method \[[@B12]\] and the most likely haplotypes within each block for individuals were inferred using the Haploview software \[[@B13]\]. Multifactor dimensionality reduction (MDR) was used to identify and characterize interactions among the SNPs and the nongenetic factors, including BMI, serum HDL, TC, and TG level, as well as percentage of smoking and alcohol abuse \[[@B14]\]. The software used for MDR is distributed in a JAVA platform with a graphical user interface and is freely available (<http://www.epistasis.org/mdr.html>).

All tests were two sided, and *P* values less than 0.05 were considered statistically significant.

3. Results {#sec3}
==========

The baseline characteristics of our study population are summarized in [Table 1](#tab1){ref-type="table"}. Age and sex distribution, HDL, smoking percentage, and percentage of alcohol abuse showed no difference between hypertensive and control groups. However, TG, TC, and BMI were significantly higher in the hypertensive group than in the control group (*P* \< 0.05).

Genotype distributions of six tagSNPs within *ADD1*gene were shown in [Table 2](#tab2){ref-type="table"}. None of them deviated from the HWE (*P* \> 0.05). Only rs4963 was significantly associated with essential hypertension (*P* = 0.02, odds ratio (OR) = 0.85, 95% confident interval (CI) = 0.75--0.97). After stratification by gender, rs4963 was associated with essential hypertension only in males, and the other 5 SNPs were still negative ([Table 3](#tab3){ref-type="table"}). We further performed haplotype analysis within LD blocks of *ADD1*. Only one LD block and three common haplotypes within the LD block (including rs16843452 and rs12503220) were identified ([Figure 1](#fig1){ref-type="fig"}). Of these three haplotypes, no haplotype was significantly associated with hypertension ([Table 4](#tab4){ref-type="table"}).

Finally, MDR was used to analyze the interaction among different SNPs and nongenetic risk factors for hypertension. After input the genotypes of 6 SNPs together with information about TG, TC, HDL, BMI, smoking, and alcohol abuse, the software outputs the best model for "BMI, rs4963, rs16843452" with 10/10 crossvalidation consistency ([Table 5](#tab5){ref-type="table"}).

4. Discussion {#sec4}
=============

Among the three adducin genes, *ADD1*has received more attention than the other two due to its association with several diseases, such as hyperlipidemia \[[@B15]\], renal disease \[[@B16]\], and coronary heart disease \[[@B17]\]. Series of studies in humans reveal that mutation of *ADD1*gene may lead to the stimulation of the sodium and potassium-adenosine triphosphatase (ATPase) activity in renal tubular cells, increased renal sodium reabsorption, and subsequently hypertension \[[@B18], [@B19]\].

Since hypertension is considered polygenic, resulting from the interaction of several genes and together with environmental factors, a single SNP has weak effects on the phenotype. A family study from van Rijin et al. \[[@B20]\] showed that *ADD1*G460W polymorphism was able to explain only a very minute proportion of the heritability of BP traits. Therefore, it is necessary to explore whether there are any other SNPs within *ADD1*gene that are also associated with essential hypertension. In order to answer this question, we carried out a case-control study in the Chinese population. The result showed that rs4963 was associated with essential hypertension, especially in males. One possible reason for this result might be that men have higher TG (1.93 versus 1.69 mM) and TC (5.39 versus 5.08 mM) level than women.

Out of 1,113 SNPs associated with *ADD1* gene \[[@B21]\], 9 are identified to be nonsynonymous by functional single-nucleotide polymorphism (F-SNP) database \[[@B22]\]. rs4963 is one of them, and the amino acid change found is from Serine to Cysteine. The G allele of rs4963 has deleterious effect by disrupting the activity of exonic splicing and thus disrupt proper gene regulation \[[@B23]\]. In current study, G allele of rs4963 increases the susceptibility of hypertension, which might be associated with altered protein structure and function.

Moreover, environmental factors and individual\'s biological characteristics, including excess dietary sodium intake, alcohol abuse, smoking, obesity, stress, BMI, TC, and TG, cannot be neglected \[[@B24], [@B25]\]. We also found interesting interactions between genetic factors and nongenetic risk factors. High BMI and serum TG level were already confirmed to be risk factors for hypertension \[[@B26]\]. The MDR analysis in this study demonstrated that these important risk factors interacted with the genetic factor. Thus, the present interaction analysis gave a little more information than the single genetic study.

In conclusion, the present study indicated that rs4963 within *ADD1*gene was associated with essential hypertension in Chinese population, which might be related to altered exonic splicing and disrupted gene regulation. Regulation of sodium transport is such a complex process that at least 189 genes are involved according to gene ontology (GO: 0002028). *ADD1*is only a common member of this system, and polymorphisms within this gene may play a tiny role. Other genes involved in sodium transport regulation system need to be studied. In addition, in our interaction analysis, a significant interaction was found between genetic and nongenetic factors, demonstrating that genetic study alone is not a sufficient indicator for hypertension. To decipher causal factors leading to the development and the pathogenesis of hypertension, future work will require analysis of gene-environmental interaction.
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###### 

Baseline characters of the investigated participants.

  Variables                  Hypertensive   Control        *P* value
  -------------------------- -------------- -------------- -------------
  Number                     905            905            N/A
  Sex (male) (%)             43.3           43.3           N/A
  Age (y)                    56.91 ± 7.37   56.60 ± 7.51   *P* = 0.38
  TG (mM)                    2.02 ± 1.68    1.63 ± 1.12    *P* \< 0.01
  HDL (mM)                   1.41 ± 0.35    1.41 ± 0.32    *P* = 0.72
  TC (mM)                    5.34 ± 1.00    5.17 ± 0.93    *P* \< 0.01
  BMI (Kg/m^2^)              24.65 ± 3.24   23.21 ± 2.86   *P* \< 0.01
  Regular smoking            173            147            *P* = 0.11
  Regular alcohol drinking   152            148            *P* = 0.80

TG: triglyceride; HDL: high density lipoprotein; TC: total cholesterol; BMI: body mass index.

###### 

Association analysis of 6 tagSNPs.

  SNP          Group          Genotype   *P* value   OR         95% CI          
  ------------ -------------- ---------- ----------- ---------- -------- ------ ------------
  rs16843452   Hypertensive   243 (CC)   462 (CT)    195 (TT)   0.89     1.01   0.89\~1.15
  Control      243 (CC)       461 (CT)   199 (TT)                               
  rs12503220   Hypertensive   11 (AA)    253 (AG)    636 (GG)   0.26     0.90   0.75\~1.08
  Control      22 (AA)        257 (AG)   624 (GG)                               
  rs4963       Hypertensive   192 (CC)   432 (CG)    278 (GG)   0.02     0.85   0.75\~0.97
  Control      224 (CC)       441 (CG)   239 (GG)                               
  rs3755885    Hypertensive   62 (CC)    379 (CG)    461 (GG)   0.24     0.92   0.79\~1.06
  Control      67 (CC)        402 (CG)   435 (GG)                               
  rs2071694    Hypertensive   447 (CC)   374 (CG)    82 (GG)    0.81     0.98   0.85\~1.13
  Control      455 (CC)       366 (CG)   83 (GG)                                
  rs3775067    Hypertensive   318 (AA)   435 (AG)    148 (GG)   0.27     1.08   0.94\~1.23
  Control      287 (AA)       469 (AG)   149 (GG)                               

OR: odds ratio; CI: confidence interval.

###### 

Association analysis of 6 tagSNPs in men and women.

  SNP          Group   *P* value   OR           95% CI
  ------------ ------- ----------- ------------ ------------
  rs16843452   Male    0.51        0.94         0.77\~1.14
  Female       0.45    1.07        0.90\~1.27   
  rs12503220   Male    0.31        0.87         0.66\~1.14
  Female       0.53    0.93        0.73\~1.17   
  rs4963       Male    0.02        0.79         0.65\~0.97
  Female       0.25    0.90        0.76\~1.07   
  rs3755885    Male    0.80        1.03         0.83\~1.28
  Female       0.08    0.84        0.69\~1.02   
  rs2071694    Male    0.28        0.89         0.72\~1.10
  Female       0.53    1.06        0.88\~1.29   
  rs3775067    Male    0.21        1.14         0.93\~1.40
  Female       0.71    1.03        0.87\~1.23   

OR: odds ratio; CI: confidence interval.

###### 

Association analysis of haplotypes with hypertension.

  Haplotype sequence   Haplotype frequency   Case/control ratio   *P* value
  -------------------- --------------------- -------------------- -----------
  TG                   0.472                 0.473, 0.470         0.840
  CG                   0.368                 0.360, 0.377         0.274
  CA                   0.157                 0.165, 0.149         0.208

###### 

MDR analysis of gene-environment interaction.

  Best model                Testing accuracy   Testing sensitivity   Testing odds ratio          Testing *χ* ^2^      Crossvalidation consistency
  ------------------------- ------------------ --------------------- --------------------------- -------------------- -----------------------------
  BMI                       0.59               0.43                  2.26 (95% CI: 1.20--4.27)   6.50 (*P* = 0.010)   10/10
  BMI, rs4963, rs16843452   0.61               0.54                  2.42 (95% CI: 1.33--4.44)   8.40 (*P* = 0.004)   10/10
  BMI, TG                   0.58               0.57                  1.98 (95% CI: 1.10--3.58)   5.18 (*P* = 0.023)   7/10
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